{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:17:36Z","timestamp":1782861456167,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22377086"],"award-info":[{"award-number":["22377086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["ZYGD23035"],"award-info":[{"award-number":["ZYGD23035"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejmech.2025.117521","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T17:36:08Z","timestamp":1742405768000},"page":"117521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Design, synthesis and biological evaluation of 3-amino-6-(2-hydroxyphenyl)pyridazin-4-aryl derivatives as SMARCA2\/4 degraders"],"prefix":"10.1016","volume":"290","author":[{"given":"Tianqiong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingping","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9297-6665","authenticated-orcid":false,"given":"Luoting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0246-8761","authenticated-orcid":false,"given":"Zhihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"37","key":"10.1016\/j.ejmech.2025.117521_bib1","doi-asserted-by":"crossref","first-page":"30897","DOI":"10.1074\/jbc.R111.309302","article-title":"SWI\/SNF chromatin-remodeling factors: multiscale analyses and diverse functions","volume":"287","author":"Euskirchen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117521_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.biochem.77.062706.153223","article-title":"The biology of chromatin remodeling complexes","volume":"78","author":"Clapier","year":"2009","journal-title":"Annu. Rev. Biochem."},{"issue":"6866","key":"10.1016\/j.ejmech.2025.117521_bib3","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/414924a","article-title":"Selectivity of chromatin-remodelling cofactors for ligand-activated transcription","volume":"414","author":"Lemon","year":"2001","journal-title":"Nature"},{"issue":"6480","key":"10.1016\/j.ejmech.2025.117521_bib4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.aaz9761","article-title":"Structure of nucleosome-bound human BAF complex","volume":"367","author":"He","year":"2020","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ejmech.2025.117521_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","article-title":"The SWI\/SNF complex in cancer - biology, biomarkers and therapy","volume":"17","author":"Mittal","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"D1","key":"10.1016\/j.ejmech.2025.117521_bib6","doi-asserted-by":"crossref","first-page":"D717","DOI":"10.1093\/nar\/gkv1275","article-title":"The UCSC Genome Browser database: 2016 update","volume":"44","author":"Speir","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"10\u201311","key":"10.1016\/j.ejmech.2025.117521_bib7","first-page":"1469","article-title":"DNA-binding properties of the recombinant high-mobility-group-like AT-hook-containing region from human BRG1 protein","volume":"387","author":"Singh","year":"2006","journal-title":"Biol. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2025.117521_bib8","doi-asserted-by":"crossref","first-page":"11268","DOI":"10.1073\/pnas.94.21.11268","article-title":"RB and hbrm cooperate to repress the activation functions of E2F1","volume":"94","author":"Trouche","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117521_bib9","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-13-3608","article-title":"SWI\/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability","volume":"74","author":"Watanabe","year":"2014","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117521_bib10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/2159-8290.CD-14-0849","article-title":"ARID1A deficiency impairs the DNA damage checkpoint and sensitizes cells to PARP inhibitors","volume":"5","author":"Shen","year":"2015","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117521_bib11","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/s41416-021-01321-0","article-title":"Achieving clinical success with BET inhibitors as anti-cancer agents","volume":"124","author":"Shorstova","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.ejmech.2025.117521_bib12","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1021\/jm200108t","article-title":"Discovery and characterization of small molecule inhibitors of the BET family bromodomains","volume":"54","author":"Chung","year":"2011","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117521_bib13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ng.2628","article-title":"Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy","volume":"45","author":"Kadoch","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117521_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-023-01736-8","article-title":"SWI\/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities","volume":"22","author":"Andrades","year":"2023","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.ejmech.2025.117521_bib15","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S1097-2765(00)00127-1","article-title":"A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI\/SNF complexes","volume":"6","author":"Bultman","year":"2000","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117521_bib16","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/1541-7786.MCR-20-0082","article-title":"Loss of SWI\/SNF chromatin remodeling alters NRF2 signaling in non-small cell lung carcinoma","volume":"18","author":"Song","year":"2020","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117521_bib17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41467-019-08380-1","article-title":"SMARCA4 loss is synthetic lethal with CDK4\/6 inhibition in non-small cell lung cancer","volume":"10","author":"Xue","year":"2019","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.ejmech.2025.117521_bib18","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1158\/0008-5472.CAN-12-4593","article-title":"A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1","volume":"73","author":"Oike","year":"2013","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117521_bib19","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1073\/pnas.1316793111","article-title":"Functional epigenetics approach identifies BRM\/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers","volume":"111","author":"Hoffman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117521_bib20","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1128\/MCB.01372-13","article-title":"Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation","volume":"34","author":"Wilson","year":"2014","journal-title":"Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.ejmech.2025.117521_bib21","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2013-02-483495","article-title":"Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance","volume":"123","author":"Buscarlet","year":"2014","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.ejmech.2025.117521_bib22","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1101\/gad.232710.113","article-title":"Role of SWI\/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation","volume":"27","author":"Shi","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2025.117521_bib23","article-title":"Compounds and uses thereof","author":"Vaswani","year":"2020","journal-title":"PatentWO2020160180"},{"issue":"22","key":"10.1016\/j.ejmech.2025.117521_bib24","doi-asserted-by":"crossref","first-page":"10155","DOI":"10.1021\/acs.jmedchem.8b01318","article-title":"Discovery of orally active inhibitors of Brahma homolog (BRM)\/SMARCA2 ATPase activity for the treatment of Brahma related gene 1 (BRG1)\/SMARCA4-Mutant cancers","volume":"61","author":"Papillon","year":"2018","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117521_bib25","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1021\/acs.jmedchem.6b00012","article-title":"Identification of a chemical probe for family VIII bromodomains through optimization of a fragment hit","volume":"59","author":"Gerstenberger","year":"2016","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117521_bib26","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/aps.2017.188","article-title":"Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay","volume":"39","author":"Lu","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"16","key":"10.1016\/j.ejmech.2025.117521_bib27","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.1021\/acs.jmedchem.2c00662","article-title":"GNE-064: a potent, selective, and orally bioavailable chemical probe for the bromodomains of SMARCA2 and SMARCA4 and the fifth bromodomain of PBRM1","volume":"65","author":"Taylor","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117521_bib28","series-title":"Therapeutic Pyridazine Compounds and Uses Thereof","author":"Alexander","year":"2016"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117521_bib29","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1021\/acs.jmedchem.4c01903","article-title":"Discovery of high-affinity SMARCA2\/4 bromodomain ligands and development of potent and exceptionally selective SMARCA2 PROTAC degraders","volume":"68","author":"Leng","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117521_bib30","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1038\/s41467-022-33430-6","article-title":"A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo","volume":"13","author":"Kofink","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117521_bib31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrd894","article-title":"ATPases as drug targets: learning from their structure","volume":"1","author":"Ch\u00e8ne","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"issue":"18","key":"10.1016\/j.ejmech.2025.117521_bib32","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1158\/0008-5472.CAN-14-3798","article-title":"The SMARCA2\/4 ATPase domain surpasses the bromodomain as a drug target in SWI\/SNF-mutant cancers: Insights from cDNA rescue and PFI-3 inhibitor studies","volume":"75","author":"Vangamudi","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117521_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114290","article-title":"The state of the art of PROTAC technologies for drug discovery","volume":"235","author":"Wang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117521_bib34","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.chembiol.2017.05.024","article-title":"Targeted protein degradation: from chemical biology to drug discovery","volume":"24","author":"Cromm","year":"2017","journal-title":"Cell Chem. Biol."},{"issue":"7893","key":"10.1016\/j.ejmech.2025.117521_bib35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-021-04246-z","article-title":"Targeting SWI\/SNF ATPases in enhancer-addicted prostate cancer","volume":"601","author":"Xiao","year":"2022","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117521_bib36","first-page":"2880","article-title":"BAF complex maintains Glioma stem cells in pediatric H3K27M Glioma","volume":"12","author":"Panditharatna","year":"2022","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117521_bib37","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1038\/s41467-022-34562-5","article-title":"Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers","volume":"13","author":"Cantley","year":"2022","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.ejmech.2025.117521_bib38","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.1021\/acs.jmedchem.3c00953","article-title":"Discovery of SMD-3040 as a potent and selective SMARCA2 PROTAC degrader with strong in vivo antitumor activity","volume":"66","author":"Yang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117521_bib39","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41589-019-0294-6","article-title":"BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design","volume":"15","author":"Farnaby","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117521_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.gde.2017.02.004","article-title":"Mammalian SWI\/SNF complexes in cancer: emerging therapeutic opportunities","volume":"42","author":"St Pierre","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117521_bib41","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/acs.jmedchem.3c01781","article-title":"PROTACs targeting BRM (SMARCA2) afford selective in vivo degradation over BRG1 (SMARCA4) and are active in BRG1 mutant xenograft tumor models","volume":"67","author":"Berlin","year":"2024","journal-title":"J. Med. Chem."},{"issue":"7451","key":"10.1016\/j.ejmech.2025.117521_bib42","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature12146","article-title":"BAF complexes facilitate decatenation of DNA by topoisomerase II\u03b1","volume":"497","author":"Dykhuizen","year":"2013","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ejmech.2025.117521_bib43","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2005-02-0734","article-title":"c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations","volume":"106","author":"Luo","year":"2005","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.ejmech.2025.117521_bib44","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.2023022832","article-title":"BRG1\/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor","volume":"143","author":"Fiskus","year":"2024","journal-title":"Blood"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:07:44Z","timestamp":1762265264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425002867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":44,"alternative-id":["S0223523425002867"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117521","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of 3-amino-6-(2-hydroxyphenyl)pyridazin-4-aryl derivatives as SMARCA2\/4 degraders","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117521"}}